Type 1 Diabetes
A Study Comparing LY900014 to Insulin Lispro in Adults With Type 1 Diabetes Using Insulin Pump Therapy
The reason for this study is to compare the study drug LY900014 to insulin lispro when both are used in insulin pump therapy in adults with type 1 diabetes (T1D).
The study will last about 23 weeks and may include up to 12 clinic visits and 2 telephone appointments.
Key Participation Requirements
All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria
- Participants must be diagnosed with type 1 diabetes and have been using insulin continuously for at least 12 months
- Participants must have been using an insulin pump with rapid-acting insulin for at least 6 months
- Participants must be using a MiniMed 530G (US), Paradigm Revel (US), or MiniMed 630G (US and Canada), MiniMed 640G or Paradigm Veo (select countries outside the US and Canada), insulin pump for at least the past 90 days